Developers of a diabetes drug may not pursue the development of the treatment after the FDA sent them a letter seeking more safety data on it. Bristol-Myers Squibb said the studies to obtain this data ...
Healthcare Cardiology Clinical Pharmacology Clinical Trials Mgmt Cosmetic Surgery Dermatology Diabetes Drug Dev't & Mfg Drug Discovery Endocrinology Family Practice Gastroenterology Geriatrics HIV/AIDS Hospital ...